These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 8077171)
1. Introduction. Part III. New agents for the treatment of depression. Greden JF J Clin Psychiatry; 1994 Feb; 55 Suppl():32-3. PubMed ID: 8077171 [No Abstract] [Full Text] [Related]
2. Half a century of antidepressant drugs: on the clinical introduction of monoamine oxidase inhibitors, tricyclics, and tetracyclics. Part I: monoamine oxidase inhibitors. López-Muñoz F; Alamo C; Juckel G; Assion HJ J Clin Psychopharmacol; 2007 Dec; 27(6):555-9. PubMed ID: 18004120 [No Abstract] [Full Text] [Related]
3. Half a century of antidepressant drugs: on the clinical introduction of monoamine oxidase inhibitors, tricyclics, and tetracyclics. Part II: tricyclics and tetracyclics. Fangmann P; Assion HJ; Juckel G; González CA; López-Muñoz F J Clin Psychopharmacol; 2008 Feb; 28(1):1-4. PubMed ID: 18204333 [No Abstract] [Full Text] [Related]
4. Psychiatric ethics and emerging issues of psychopharmacology in the treatment of depression. Cohan JA J Contemp Health Law Policy; 2003; 20(1):115-72. PubMed ID: 15067929 [No Abstract] [Full Text] [Related]
6. [Therapy with neuroleptics and antidepressive agents: a fundamental and critical discussion from a biological viewpoint]. Langer G Wien Klin Wochenschr; 1983 Jul; 95(14):474-8. PubMed ID: 6138904 [TBL] [Abstract][Full Text] [Related]
7. Milestones in clinical pharmacology. Psychopharmacology--depression and anxiety. Farrar GE Clin Ther; 1991; 13(4):521-4. PubMed ID: 1934004 [No Abstract] [Full Text] [Related]
8. A decade of antidepressant development: the SSRIs and beyond. Judd LL J Affect Disord; 1998 Dec; 51(3):211-3. PubMed ID: 10333978 [No Abstract] [Full Text] [Related]
9. A brief history of depression. Johns Hopkins Med Lett Health After 50; 1999 Jun; 11(4):7. PubMed ID: 10377903 [No Abstract] [Full Text] [Related]
10. The mousetrap: managing the placebo effect in antidepressant trials. Lakoff A Mol Interv; 2002 Apr; 2(2):72-6. PubMed ID: 14993352 [No Abstract] [Full Text] [Related]
11. Introduction: new directions in the treatment of atypical depression. Thase ME J Clin Psychiatry; 2007; 68 Suppl 3():4-9. PubMed ID: 17348761 [No Abstract] [Full Text] [Related]
12. Introduction. Reboxetine: a new selective antidepressant for the treatment of depression. Montgomery SA; Schatzberg AF J Clin Psychiatry; 1998; 59 Suppl 14():3. PubMed ID: 9818622 [No Abstract] [Full Text] [Related]
14. [Clinical use of new antidepressive agents with dual action (literature review)]. De León OA Rev Med Panama; 2000; 25():24-9. PubMed ID: 15881744 [TBL] [Abstract][Full Text] [Related]
15. [New options in the treatment of depression]. Frieling H; Hillemacher T; Demling JH; Kornhuber J; Bleich S Fortschr Neurol Psychiatr; 2007 Nov; 75(11):641-52. PubMed ID: 17366379 [TBL] [Abstract][Full Text] [Related]
16. Major depression: assessing the role of new antidepressants. Vanderhoff BT; Miller KE Am Fam Physician; 1997 Jan; 55(1):249-54, 259-60. PubMed ID: 9012282 [TBL] [Abstract][Full Text] [Related]
17. [Psychopharmacotherapy in the 20th century]. Siepmann M; Kirch W Wien Med Wochenschr; 2001; 151(15-17):397-402. PubMed ID: 11603211 [TBL] [Abstract][Full Text] [Related]
18. History and evolution of the monoamine hypothesis of depression. Hirschfeld RM J Clin Psychiatry; 2000; 61 Suppl 6():4-6. PubMed ID: 10775017 [TBL] [Abstract][Full Text] [Related]
19. New and future treatment of depression. Hooper JF Ala Med; 1989 Dec; 59(6):23-5. PubMed ID: 2624246 [No Abstract] [Full Text] [Related]